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ABSTRACT 
Objective:  Analyzing the rate of complications after endoscopic transsphenoidal surgery for removal of pituitary 
adenomas in neurosurgery department lady reading hospital Peshawar. 
Materials and Methods:  Retrospective study of 58 patients who underwent endoscopic transsphenoidal surgery 
for pituitary adenomas between July 2013 and June 2016. The Criteria for diagnosis of complications were 
clinical and radiological. 
Results:  11 (18.96%) of the 58 patients who underwent endoscopic transsphenoidal surgery developed per-
operative or postoperative complications most of which were managed successfully resulting in good outcome. 
Conclusion:  The rate of complications observed in our hospital are comparable to those in the international 
literature. There is a drop in the rate of complications with increasing experience of the neurosurgeon. 
Abbreviations:  Pts: Pituitary Tumors. TSS: Transsphenoidal Surgery. DI: Diabetes Insipidus. CSF: Cerebro-
spinal Fluid. ICA: Internal Carotid Artery. 
 
INTRODUCTION 
Pituitary tumors (PTs) are a group of tumors, with an 
approximate prevalence of 15% of brain tumors. 
Majority of PTs originate from adenohypophyseal 
cells of the pituitary, and are mostly benign adeno-
mas.
1
 Majority of these are asymptomatic, they may 
become symptomatic due to mass effect on surround-
ing structures or secrete pituitary hormones causing 
various endocrinologic symptoms. Main treatment 
modalities available are medical, surgical and radiation 
therapy.
2
 Surgical resection is the primary treatment of 
choice for most patients with symptomatic tumors. 
Transsphenoidal surgery (TSS) is the first choice of 
treatment for pituitary tumors, it is less invasive, suc-
cessful and having less complications. Decompression 
of visual apparatus and other surrounding anatomical 
structures is also done adequately.
3-5
 
 With the introduction of the endoscope to endo-
nasal pituitary surgery in the last 20 years has been a 
key milestone in the field of neuroendoscopy and have 
helped neurosurgeon in resection of these tumors with 
small portals and have also resulted in less morbidity 
and mortality ranging from 0% to 20%.
4,6,8,10
 The main 
type of complications are dural tears, meningitis, peri-
operative bleeding, vascular injuries, orbital injuries, 
cerebrospinal fluid (CSF) leak, permanent diabetes 
insipidus (DI), and permanent endocrinologic seq-
uale.
14-17,19
 The goal of this study is to determine the 
rate of complications following primary transsphe-
noidal surgery for pituitary tumors in our own setup. 
 
MATERIALS AND METHODS 
This study is a descriptive retrospective analysis of 58 
patients who underwent a primary transsphenoidal 
resection of a pituitary tumors (PT) in the department 
of neurosurgery unit B lady reading hospital from 01 
July 2013 to 30 June 2016 (3 year). All clinical and 
surgical data were collected from patients, hospital 
charts and in follow up in outpatient department regar-
ding tumor size, symptoms, and residual tumor after 
surgery, functional hormonal remission, symptom rel-
ief, and complications. All patients underwent neuro-
logical, ophthalmological, and endocrinological exa-
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minations before and after resection. But primary 
outcome of interest was the rate of major and minor 
surgical complications. The institutional review board 
of Medical teaching institution lady reading hospital 
approved this study. 
 All cases of recurrent tumors were excluded from 
surgery due to the fact that complication rate are hi-
gher in these recurrent cases because of altered ana-
tomy due to previous surgery and surgically induced 
fibrosis. Data analysis was done on SPSS version 20 
and data presented in charts and tables. 
 
RESULTS 
A total of 58 consecutive patients underwent endo-
scopic transsphenoidal procedures for pituitary adeno-
mas. The age of this patient cohort ranged from 34 to 
68 years (mean: 54 years). The mean follow-up was of 
15 months (range: 2 – 24 Months). 31 had functioning 
adenomas, of functioning tumors 11 had GH produc-
ing tumors, 9 had Cushing’s disease, and 11 had pro-
lactinomas (Figure 1, 2). Of these functioning adeno-
mas, 24 were macroadenomas and 7 were micro ade-
nomas; 27 cases were non-functioning macroadeno-
mas. Among macroadenomas, 16 had suprasellar and 
five had suprasellar and parasellar extension. 18 pati-
ents had hormone levels at the upper limit of normal 
range. The mean follow-up of functioning adenomas 
was eight months (range = 4 – 17 months). Of the 58 
pituitary adenomas, total tumor removal was achieved 
in 86% of patients. Among patients who presented 
with non-functioning pituitary adenomas, total tumor 
removal was achieved in 91%. 87% of the functioning 
adenomas improved. Compressive symptoms related 
to optic apparatus compression due to macroadenomas 
were relieved in 85% of these patients. 
 Hormonal remission was achieved in 78% of pat-
ients during last follow-up for growth and cortisol. 
Four cases presented failure of hormonal remission; 
two GH tumors with suprasellar, parasellar extension 
and cavernous sinus extension, and the other two with 
Cushing’s disease with micro adenoma not visible dur-
ing surgery, despite surgical exploration of the pitu-
itary gland with approximately 3 mm of size at MRI. 
 Surgery-related complications were observed in 11 
cases (18.96%); most were easily managed during 
surgery or post operatively, not withstanding one 
carotid artery injury resulting in fatal immediate post 
op bleeding and death of patient. CSF leakage and 
infection was among the most common complication 
(3.44% each). During surgery some CSF leak was 
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Fig. 1:  Functional Status of Tumors (n = 58). 
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Fig. 2:  Classification of Functional Tumors (n = 31). 
 
observed in 6 patient. In all of them, the arachnoid 
opening was repaired by a routine multilayer closure 
using fat tissue graft, fascia lata graft, bone or cartilage 
and a pedicle mucosal flap. In cases of high volume 
CSF leaks, a vascularized nasal septal flap was raised 
for seller roof repair
22
. Post-operative CSF leak occu-
rred in 2 patients (3.44%) and were treated with lum-
bar drains; two of these cases required further surgical 
exploration of the sphenoid sinus. Diabetes Insipidus, 
septal perforation, DVT and pulmonary embolism, 
anterior pituitary insufficiency, carotid artery injury 
and opthalmoplegia occurred in one patient each 
(1.72%). 
 One patient (1.72%) suffered major bleeding and 
death after the opening of the seller floor due to injury 
to the internal carotid artery (ICA). 
 
DISCUSSION 
Among the 63 cases of transsphenoidal surgery for PT
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identified, 58 primary cases met inclusion criteria. 
The mean age of the included population was 51. The 
most common primary endoscopic transsphenoidal 
procedure performed in this cohort was a partial/ 
complete excision of the pituitary tumor. Complicat-
ion occurred in 11 patients, complications identified 
peroperatively or postoperatively were successfully 
managed in 10 patient. One fatal complication in form 
of internal carotid artery injury proved fatal resulting 
in mortality of 1.72%. Patient age, type of neoplasm 
(benign, uncertain, or malignant), size of tumor and 
invasion of surrounding structures were predictors of 
complications following surgery. Surgical complicat-
ions were more common in cases with a diagnosis of a 
malignant neoplasm as compared to benign tumor. 
Structural complications rate was also higher in pat-
ient with acromegaly. Endocrinologic complication 
rate was high in patient having preoperatively hor-
monal imbalances. 
 
Table 1: Post-operative complications of EETSS 
(n = 58). 
 
Complications 
No. of 
Patients 
Percentage 
CSF Rhinorrhea 2 3.44 
Diabetes Insipidus 1 1.72 
Septal perforation 1 1.72 
DVT and pulmonary embolism 1 1.72 
Anterior pituitary insufficiency 1 1.72 
Carotid artery injury 1 1.72 
Meningitis 2 3.44 
Opthalmoplegia 1 1.72 
Death 1 1.72 
 
 Study by Berkeret al.
20
 noted same percentage of 
complications and our result is comparable to other 
studies done on same topic. Higher rates of complicat-
ions were shown in a meta-analysis
21
 published in 
2012 containing 38 studies with 2,125 endoscopic and 
3,518 microscopic approaches. In this study compli-
cation rates were similar when comparing endoscopic 
to microscopic approaches, with only the rate of 
vascular complications being statistically significantly 
higher in the endoscopic group. In the endoscopic 
group, this study noted a death rate of 0.49% with 
complications including CSF leak in 7.0%, meningitis 
in 1.1%, vascular complication in 1.6%, visual loss in 
0.7%, transient DI in9.1%, and permanent DI in 2.31% 
of patients. As compared to these and earlier studies,
7-
9,12,23
 the rate of complications following transsphe-
noidal pituitary surgery in this cohort was compara-
tively low, with 8.39% of primary cases resulting in 
complications. 
 
CONCLUSIONS 
Transphenoidal surgery is the first choice of treatment 
after failed appropriate medical treatment because of 
less invasiveness, less complication, high success rate 
and its easy availability in most tertiary neurosurgical 
centers. 
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